Folkert M. Morsink

Utrecht, UT, Netherlands

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 28 publications

Emergence of oncofetal plasticity is ubiquitous in early colorectal cancers.

Emergence of oncofetal plasticity is ubiquitous in early colorectal cancers.

Journal: Nature
Published: March 07, 2025

Intestinal LKB1 Loss Drives a Premalignant Program Along the Serrated Cancer Pathway.

Intestinal LKB1 Loss Drives a Premalignant Program Along the Serrated Cancer Pathway.

Journal: Gastroenterology
Published: August 14, 2024

Diagnostic Utility of Menin Immunohistochemistry in Patients With Multiple Endocrine Neoplasia Type 1 Syndrome.

Diagnostic Utility of Menin Immunohistochemistry in Patients With Multiple Endocrine Neoplasia Type 1 Syndrome.

Journal: The American journal of surgical pathology
Published: May 18, 2023

Metastatic Patterns of Duodenopancreatic Neuroendocrine Tumors in Patients With Multiple Endocrine Neoplasia Type 1.

Metastatic Patterns of Duodenopancreatic Neuroendocrine Tumors in Patients With Multiple Endocrine Neoplasia Type 1.

Journal: The American journal of surgical pathology
Published: September 24, 2021

Genome Methylation Accurately Predicts Neuroendocrine Tumor Origin: An Online Tool.

Genome Methylation Accurately Predicts Neuroendocrine Tumor Origin: An Online Tool.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: August 19, 2020

Status of CHEK2 and p53 in patients with early-onset and conventional gastric cancer.

Status of CHEK2 and p53 in patients with early-onset and conventional gastric cancer.

Journal: Oncology letters
Published: August 07, 2020

Non-functional pancreatic neuroendocrine tumours: ATRX/DAXX and alternative lengthening of telomeres (ALT) are prognostically independent from ARX/PDX1 expression and tumour size.

Non-functional pancreatic neuroendocrine tumours: ATRX/DAXX and alternative lengthening of telomeres (ALT) are prognostically independent from ARX/PDX1 expression and tumour size.

Journal: Gut
Published: July 21, 2020

High-Throughput Sequencing of Gastric Cancer Patients: Unravelling Genetic Predispositions Towards an Early-Onset Subtype.

High-Throughput Sequencing of Gastric Cancer Patients: Unravelling Genetic Predispositions Towards an Early-Onset Subtype.

Journal: Cancers
Published: June 27, 2020

The decisive role of molecular pathology in presumed somatic metastases of type II testicular germ cell tumors: report of 2 cases.

The decisive role of molecular pathology in presumed somatic metastases of type II testicular germ cell tumors: report of 2 cases.

Journal: Diagnostic pathology
Published: April 26, 2020

Alternative Lengthening of Telomeres and Differential Expression of Endocrine Transcription Factors Distinguish Metastatic and Non-metastatic Insulinomas.

Alternative Lengthening of Telomeres and Differential Expression of Endocrine Transcription Factors Distinguish Metastatic and Non-metastatic Insulinomas.

Journal: Endocrine pathology
Published: February 28, 2020

Expression of cyclooxygenase-2 and mucin 1 in colorectal cancer.

Expression of cyclooxygenase-2 and mucin 1 in colorectal cancer.

Journal: Molecular and clinical oncology
Published: January 22, 2020

Assessment of ARX expression, a novel biomarker for metastatic risk in pancreatic neuroendocrine tumors, in endoscopic ultrasound fine-needle aspiration.

Assessment of ARX expression, a novel biomarker for metastatic risk in pancreatic neuroendocrine tumors, in endoscopic ultrasound fine-needle aspiration.

Journal: Diagnostic cytopathology
Published: October 29, 2019
Showing 1-12 of 28

Last Updated: 09/26/2026